Implementation of reflexive genomic profiling in non-squamous NSCLC: Results of single center experience

被引：0
|
作者：
Brown, Jacqueline T.
Moore, Andrew R.
Reuss, Joshua E.
Simon, Nicholas I.
Gentzler, Ryan D.
Hall, Richard Delmar
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e13010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13010
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Effects on immunotherapy of EGFR mutation subtypes in non-squamous NSCLC.
    Tang, Haibo
    Li, Xiaoning
    Xie, Wenzhuan
    Huang, Mengli
    CANCER RESEARCH, 2021, 81 (13)
  • [22] A single-center experience of comprehensive genomic profiling of hepatobiliary and pancreatic cancers
    Eguchi, Hiroki
    Imaoka, Hiroshi
    Inoue, Kanae
    Taira, Tomonao
    Okumura, Kei
    Shibuki, Taro
    Watanabe, Kazuo
    Sasaki, Mitsuhito
    Mitsunaga, Shuichi
    Ikeda, Masafumi
    ANNALS OF ONCOLOGY, 2022, 33 : S496 - S496
  • [23] ALK/EML4 translocation in non-squamous NSCLC and their predictors
    Dias, Margarida
    Linhas, Rita
    Antunes, Ana
    Campainha, Sergio
    Conde, Sara
    Barroso, Ana
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [24] THE EFFECT OF PEMETREXED CONTAINING REGIMES ON OVERALL SURVIVAL IN NON-SQUAMOUS NSCLC
    Stevens, R.
    Booth, H.
    Button, M.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S74 - S74
  • [25] Real-world evidence of first-line pembrolizumab plus chemotherapy in metastatic non-squamous NSCLC: A single-centre experience
    Bose, Subhadeep
    Khaja, Mujtaba Syed
    Siva, Asha
    Wilson, Paula
    Grist, Helen
    Murukesh, Nishanth
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] Promising targets and current clinical trials in metastatic non-squamous NSCLC
    Zer, Alone
    Leighl, Natasha
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [27] Cost-effectiveness of liquid biopsy for molecular profiling of newly diagnosed advanced non-squamous NSCLC in an Asian population
    Tan, Aaron C.
    Liu, Sibo
    Graves, Nicholas
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : 178 - 178
  • [28] Clinical immune and genomic profiling of STK11 mutant non-squamous non-small cell lung cancer
    Yau, Edwin
    Pabla, Sarabjot
    Glenn, Sean
    Papanicolau-Sengos, Antonios
    Nesline, Mary
    Dy, Grace
    Morrison, Carl
    CANCER RESEARCH, 2020, 80 (16)
  • [29] PEMETREXED IN COMBINATION WITH CISPLATIN IN THE FIRST-LINE TREATMENT OF NON-SQUAMOUS NSCLC: CZECH EXPERIENCE WITH 233 PATIENTS
    Skrickova, Jana
    Bortlicek, Zdenek
    Hejduk, Karel
    Pesek, Milos
    Kolek, Vitezslav
    Koubkova, Leona
    Roubec, Jaromir
    Tomiskova, Marcela
    Satankova, Monika
    Povolna, Zdenka
    Havel, Libor
    Coupkova, Helena
    Salajka, Frantisek
    Hrnciarik, Michal
    Zemanova, Milada
    Sixtova, Dimka
    Cernovska, Marketa
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S864 - S864
  • [30] Pemetrexed and carboplatin plus bevacizumab for advanced non-squamous non-small cell lung cancer (NSCLC): Preliminary results
    Patel, J. D.
    Hensing, T. A.
    Villafor, V.
    Hart, E.
    Bonomi, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345